The α₂ adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates.

Johnston, Tom H

The α₂ adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates. [electronic resource] - Movement disorders : official journal of the Movement Disorder Society Oct 2010 - 2084-93 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1531-8257

10.1002/mds.23172 doi


Adrenergic alpha-2 Receptor Antagonists--pharmacology
Analysis of Variance
Animals
Disability Evaluation
Disease Models, Animal
Dopamine Agents--adverse effects
Drug Therapy, Combination--methods
Dyskinesia, Drug-Induced--drug therapy
Female
Imidazoles--pharmacology
Indans--pharmacology
Levodopa--adverse effects
Macaca fascicularis
Male
Motor Activity--drug effects
Parkinsonian Disorders--drug therapy
Time Factors